1 of 1
Story summary
- Medicare launched its first hemp pilot program, allowing eligible patients to receive up to $500 annually for hemp-derived cannabidiol (CBD) products, effective April 1, 2026.
- Louisville-based companies Cornbread Hemp and Alliant Purchasing collaborate on the program.
- The initiative marks a shift in federal policy toward cannabis-derived therapies.
- Lawsuits from anti-marijuana groups challenge the program.
- A looming federal hemp ban is set for November 2026.
